药剂师主导干预措施改善痛风结果的有效性:系统性审查
Maria Tanveer1, Azhar Hussain Tahir2, Sunil Shrestha3
1School of Clinical Sciences, Faculty of Health, Queensland University of Technology, Queensland, Australia.
Research in social & administrative pharmacy : RSAP
|July 3, 2025
概括
药剂师主导的干预措施通过提高患者教育,药物坚持和减少发作,显著改善了痛风管理. 这次审查强调了它们在控制血清尿酸水平和改善患者生活质量的关键作用.
科学领域:
- 药理学和制药护理 药理学和制药护理
- 风湿病学和慢性疾病管理
背景情况:
- 药剂师是医疗保健的组成部分,提供超出药物发行之外的重要患者支持.
- 它们在治疗痛风等慢性疾病中的作用是显著的,但它们影响的证据尚不清楚.
研究的目的:
- 系统地审查药剂师主导干预措施对痛风结果的影响.
- 关键的结果包括血清尿酸水平,药物坚持和患者教育.
主要方法:
- 在PubMed,Embase和Cochrane图书馆进行了全面的搜索,截至2025年4月.
- 包括随机对照试验 (RCT) 和非随机研究 (非RCT) 评估药剂师对痛风的干预措施.
- 结果:血清尿酸水平,痛风发作,坚持,患者教育和诊所访问频率. 使用ROB-2和ROBINS-I工具进行偏差风险评估.
主要成果:
- 纳入了5项涉及1805名参与者的研究 (2项RCT,3项非RCT).
- 药剂师干预改善了目标血清尿酸水平,药物坚持,并减少了痛风发作.
- 随机试验表明与非随机研究相比,偏差风险较低.
结论:
- 药剂师参与痛风管理可以改善疾病控制和患者的生活质量.
- 需要进一步的研究来确定最佳干预组件及其长期影响.
相关概念视频
Peripheral Artery Disease III: Interprofessional Care
32
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
32
Peptic Ulcer Disease IV: Management
148
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
148
Chronic Kidney Disease III: Interprofessional Care
82
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
82
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
46
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
46
Peripheral Artery Disease IV: Nursing Management
46
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
46
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
258
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
258


